SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000849146-24-000016
Filing Date
2024-01-30
Accepted
2024-01-30 16:05:31
Documents
46
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q lfvn-20231231.htm   iXBRL 10-Q 853195
2 EX-31.1 lfvn_123123xex311.htm EX-31.1 9635
3 EX-31.2 lfvn_123123xex312.htm EX-31.2 9615
4 EX-32.1 lfvn_123123xex321.htm EX-32.1 4941
5 EX-32.2 lfvn_123123xex322.htm EX-32.2 4921
  Complete submission text file 0000849146-24-000016.txt   4125273

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lfvn-20231231.xsd EX-101.SCH 24599
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lfvn-20231231_cal.xml EX-101.CAL 57503
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lfvn-20231231_def.xml EX-101.DEF 95530
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lfvn-20231231_lab.xml EX-101.LAB 393377
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lfvn-20231231_pre.xml EX-101.PRE 229689
48 EXTRACTED XBRL INSTANCE DOCUMENT lfvn-20231231_htm.xml XML 450078
Mailing Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043
Business Address 3300 TRIUMPH BLVD SUITE 700 LEHI UT 84043 801-432-9000
Lifevantage Corp (Filer) CIK: 0000849146 (see all company filings)

IRS No.: 900224471 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-35647 | Film No.: 24578175
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)